A compound for the treatment of a disease associated with a desegregation of the alternative complement pathway

摘要

The present invention relates to a compound for the treatment and / or prophylaxis and / or diagnosis of a disease associated with a deregulation, preferably a dysregulated activation, more preferably a hyperactivation of the alternative complement pathway. It also relates to a pharmaceutical and diagnostic composition comprising the compound of the invention. It further relates to the use of the compound of the invention in vitro for inhibiting the activation of proCFD in a biological sample.